The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The correlation between molecular characteristics and treatment outcomes in patients (pts) with grade 2-3 (G2-3) gliomas.
 
Jaleh Fallah
No Relationships to Disclose
 
Vineeth Tatineni
No Relationships to Disclose
 
Martin C. Tom
No Relationships to Disclose
 
Wei Wei
No Relationships to Disclose
 
Deborah Park
No Relationships to Disclose
 
Surabhi Tewari
No Relationships to Disclose
 
Glen Stevens
No Relationships to Disclose
 
Samuel T. Chao
Honoraria - Varian Medical Systems
 
John H. Suh
Consulting or Advisory Role - Abbvie; Neutron Therapeutics; Phillips Gilmore Oncology
 
David M. Peereboom
Consulting or Advisory Role - Orbus Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mylan (Inst); Neonc Technologies (Inst); Novartis (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Stemline Therapeutics
 
Erin Sennett Murphy
No Relationships to Disclose
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MimiVax
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Flatiron Health; FORMA Therapeutics; Kadmon; Karyopharm Therapeutics; Tocagen; Varian Medical Systems; VBI Vaccines
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst)